Paraffin liquid — avene

Labeling of immediate packaging
(PE bottle, 500 g)
Packaging intended for use in closed medical care
Parafina ciekła - Avena
Paraffinum liquidum
Oral and topical liquid, 1g/1g
Packaging content: 500 g
Composition:
1 g of liquid contains 1 g of liquid paraffin.
Indications:
Laxative used in constipation as directed by a physician.
Externally for skin massage.
Contraindications:
Hypersensitivity to liquid paraffin. Abdominal pain of unknown cause and
acute inflammatory conditions of the gastrointestinal tract, e.g. appendicitis.
Children and pregnant women should not be given the medicine without
consulting a physician.
Special warnings and precautions for use:
For skin: lack of data. Orally: the medicine is used as a short-term laxative.
If symptoms worsen or laxative effect does not occur within 1–2 days, consult a physician.
Prolonged and non-compliant use of the medicine may lead to
water-electrolyte imbalance and secondary constipation. Use with particular caution in patients with chronic inflammatory conditions in the abdomen, as well as in pregnant and breastfeeding women.
Accidental aspiration of paraffin into the respiratory tract may cause
very severe pneumonia. The risk particularly concerns elderly, debilitated patients, and those taking the medicine in a lying position (choking). In elderly patients, administration should be limited to truly necessary situations, using the lowest effective doses for as short a time as possible (2–3 weeks). Due to the risk of adverse effects, duration and frequency of use should be monitored in elderly patients.
Interactions:
For skin: lack of data. Orally: the medicine used may interfere with the absorption of fat-soluble vitamins, i.e. A, D, E and K, as well as concurrently administered oral medicines.
Use during pregnancy and breastfeeding:
For skin: no contraindications. Orally: consult a physician before use.
Effect on ability to drive and operate machinery:
The medicine does not affect psycho-physical performance.
Route and method of administration:
Packaging intended for use in closed medical care. The product should be used according to physician's instructions.
Overdose:
Administration of large doses may cause diarrhea.
Adverse effects:
For skin: not reported so far. Orally: may cause anal itching; paraffin leakage from the anus is frequently observed. Prolonged and non-compliant use of the medicine may lead to water-electrolyte imbalance and secondary constipation. Small amounts of liquid paraffin may accumulate in lymph nodes, causing inflammatory changes.
Storage:
Keep the medicine out of reach and sight of children.
Store in a dark place. Do not use after the expiry date.
Availability category: OTC - Medicinal product dispensed without prescription.
Expiry date: (month, year)
Responsible party: Laboratorium Farmaceutyczne „Avena” spółka jawna
Sokulska- Dura i Palmowski
ul. Leśna 42, 86-031 Osielsko
tel.: (052) 324 12 12
fax.: (052) 324 12 11
Permit number: IL – 3385/LN
Batch number:
EAN UCC barcode: 5909994338548

Information provided
in Braille system:
Labeling of immediate packaging
(PE bottle, 800 g)
Packaging intended for use in closed medical care
Parafina ciekła - Avena
Paraffinum liquidum
Oral and topical liquid, 1g/1g
Packaging content: 800 g
Composition:
1 g of liquid contains 1 g of liquid paraffin.
Indications:
Laxative used in constipation (as directed by a physician).
Externally for skin massage.
Contraindications:
Hypersensitivity to liquid paraffin. Abdominal pain of unknown cause and
acute inflammatory conditions of the gastrointestinal tract, e.g. appendicitis.
Children and pregnant women should not be given the medicine without
consulting a physician.
Special warnings and precautions for use:
For skin: lack of data. Orally: the medicine is used as a short-term laxative.
If symptoms worsen or laxative effect does not occur within 1–2 days, consult a physician.
Prolonged and non-compliant use of the medicine may lead to
water-electrolyte imbalance and secondary constipation. Use with particular caution in patients with chronic inflammatory conditions in the abdomen, as well as in pregnant and breastfeeding women.
Accidental aspiration of paraffin into the respiratory tract may cause
very severe pneumonia. The risk particularly concerns elderly, debilitated patients, and those taking the medicine in a lying position (choking). In elderly patients, administration should be limited to truly necessary situations, using the lowest effective doses for as short a time as possible (2–3 weeks). Due to the risk of adverse effects, duration and frequency of use should be monitored in elderly patients.
Interactions:
For skin: lack of data. Orally: the medicine used may interfere with the absorption of fat-soluble vitamins, i.e. A, D, E and K, as well as concurrently administered oral medicines.
Use during pregnancy and breastfeeding:
For skin: no contraindications. Orally: consult a physician before use.
Effect on ability to drive and operate machinery:
The medicine does not affect psycho-physical performance.
Route and method of administration:
Packaging intended for use in closed medical care. The medicine should be used according to physician's instructions.
Overdose:
Administration of large doses may cause diarrhea.
Adverse effects:
For skin: not reported so far. Orally: may cause anal itching; paraffin leakage from the anus is frequently observed. Prolonged and non-compliant use of the medicine may lead to water-electrolyte imbalance and secondary constipation. Small amounts of liquid paraffin may accumulate in lymph nodes, causing inflammatory changes.
Storage:
Keep the medicine out of reach and sight of children.
Store in a dark place. Do not use after the expiry date.
Availability category: OTC - Medicinal product dispensed without prescription.
Expiry date: (month, year)
Responsible party: Laboratorium Farmaceutyczne „Avena” spółka jawna
Sokulska- Dura i Palmowski
ul. Leśna 42, 86-031 Osielsko
tel.: (052) 324 12 12
fax.: (052) 324 12 11
Permit number IL – 3385/LN
Batch number:
EAN UCC barcode: 5909994338555

Information provided
in Braille system:
Labeling of immediate packaging (bottle, 40 g)
Parafina ciekła - Avena
Paraffinum liquidum
Oral and topical liquid, 1g/1g
Packaging content: 40 g
Composition:
1 g of liquid contains 1 g of liquid paraffin.
Indications:
Laxative used in constipation (as directed by a physician).
Externally for skin massage.
Contraindications:
Hypersensitivity to liquid paraffin. Abdominal pain of unknown cause and
acute inflammatory conditions of the gastrointestinal tract, e.g. appendicitis.
Children and pregnant women should not be given the medicine without
consulting a physician.
Special warnings and precautions for use:
For skin: lack of data. Orally: the medicine is used as a short-term laxative.
If symptoms worsen or laxative effect does not occur within 1–2 days, consult a physician.
Prolonged and non-compliant use of the medicine may lead to
water-electrolyte imbalance and secondary constipation. Use with particular caution in patients with chronic inflammatory conditions in the abdomen, as well as in pregnant and breastfeeding women.
Accidental aspiration of paraffin into the respiratory tract may cause
very severe pneumonia. The risk particularly concerns elderly, debilitated patients, and those taking the medicine in a lying position (choking). In elderly patients, administration should be limited to truly necessary situations, using the lowest effective doses for as short a time as possible (2–3 weeks). Due to the risk of adverse effects, duration and frequency of use should be monitored in elderly patients.
Interactions:
For skin: lack of data. Orally: the medicine used may interfere with the absorption of fat-soluble vitamins, i.e. A, D, E and K, as well as concurrently administered oral medicines.
Use during pregnancy and breastfeeding:
For skin: no contraindications. Orally: consult a physician before use.
Effect on ability to drive and operate machinery:
The medicine does not affect psycho-physical performance.
Route and method of administration:
For skin: in adults and children, massage skin with a small amount of preparation as needed. Orally: unless otherwise directed by a physician: adults – usually 15–30 ml orally before bedtime (corresponding to 1–2 tablespoons).
Laxative effect usually occurs after 6–10 hours.
Overdose:
Administration of large doses may cause diarrhea.
Adverse effects:
For skin: not reported so far. Orally: may cause anal itching; paraffin leakage from the anus is frequently observed. Prolonged and non-compliant use of the medicine may lead to water-electrolyte imbalance and secondary constipation. Small amounts of liquid paraffin may accumulate in lymph nodes, causing inflammatory changes.
Storage:
Keep the medicine out of reach and sight of children.
Store in a dark place. Do not use after the expiry date.
Availability category: OTC - Medicinal product dispensed without prescription.
Expiry date: (month, year)
Responsible party: Laboratorium Farmaceutyczne „Avena” spółka jawna
Sokulska- Dura i Palmowski
ul. Leśna 42, 86-031 Osielsko
tel.: (052) 324 12 12
fax.: (052) 324 12 11
Permit number: IL – 3385/LN
Batch number:
EAN UCC barcode: 5909994338517

Information provided
in Braille system:
Labeling of immediate packaging (bottle, 80 g)
Parafina ciekła - Avena
Paraffinum liquidum
Oral and topical liquid, 1g/1g
Packaging content: 80 g
Composition:
1 g of liquid contains 1 g of liquid paraffin.
Indications:
Laxative used in constipation as directed by a physician.
Externally for skin massage.
Contraindications:
Hypersensitivity to liquid paraffin. Abdominal pain of unknown cause and
acute inflammatory conditions of the gastrointestinal tract, e.g. appendicitis.
Children and pregnant women should not be given the medicine without
consulting a physician.
Special warnings and precautions for use:
For skin: lack of data. Orally: the medicine is used as a short-term laxative.
If symptoms worsen or laxative effect does not occur within 1–2 days, consult a physician.
Prolonged and non-compliant use of the medicine may lead to
water-electrolyte imbalance and secondary constipation. Use with particular caution in patients with chronic inflammatory conditions in the abdomen, as well as in pregnant and breastfeeding women.
Accidental aspiration of paraffin into the respiratory tract may cause
very severe pneumonia. The risk particularly concerns elderly, debilitated patients, and those taking the medicine in a lying position (choking). In elderly patients, administration should be limited to truly necessary situations, using the lowest effective doses for as short a time as possible (2–3 weeks). Due to the risk of adverse effects, duration and frequency of use should be monitored in elderly patients.
Interactions:
For skin: lack of data. Orally: the medicine used may interfere with the absorption of fat-soluble vitamins, i.e. A, D, E and K, as well as concurrently administered oral medicines.
Use during pregnancy and breastfeeding:
For skin: no contraindications. Orally: consult a physician before use.
Effect on ability to drive and operate machinery:
The medicine does not affect psycho-physical performance.
Route and method of administration:
For skin: in adults and children, massage skin with a small amount of preparation as needed. Orally: unless otherwise directed by a physician: adults – usually 15–30 ml orally before bedtime (corresponding to 1–2 tablespoons).
Laxative effect usually occurs after 6–10 hours.
Overdose:
Administration of large doses may cause diarrhea.
Adverse effects:
For skin: not reported so far. Orally: may cause anal itching; paraffin leakage from the anus is frequently observed. Prolonged and non-compliant use of the medicine may lead to water-electrolyte imbalance and secondary constipation. Small amounts of liquid paraffin may accumulate in lymph nodes, causing inflammatory changes.
Storage:
Keep the medicine out of reach and sight of children.
Store in a dark place. Do not use after the expiry date.
Availability category: OTC - Medicinal product dispensed without prescription.
Expiry date: (month, year)
Responsible party: Laboratorium Farmaceutyczne „Avena” spółka jawna
Sokulska- Dura i Palmowski
ul. Leśna 42, 86-031 Osielsko
tel.: (052) 324 12 12
fax.: (052) 324 12 11
Permit number: IL – 3385/LN
Batch number:
EAN UCC barcode: 5909994338524

Information provided
in Braille system:
Labeling of immediate packaging (bottle, 100 g)
Parafina ciekła - Avena
Paraffinum liquidum
Oral and topical liquid, 1g/1g
Packaging content: 100 g
Composition:
1 g of liquid contains 1 g of liquid paraffin.
Indications:
Laxative used in constipation as directed by a physician.
Externally for skin massage.
Contraindications:
Hypersensitivity to liquid paraffin. Abdominal pain of unknown cause and
acute inflammatory conditions of the gastrointestinal tract, e.g. appendicitis.
Children and pregnant women should not be given the medicine without
consulting a physician.
Special warnings and precautions for use:
For skin: lack of data. Orally: the medicine is used as a short-term laxative.
If symptoms worsen or laxative effect does not occur within 1–2 days, consult a physician.
Prolonged and non-compliant use of the medicine may lead to
water-electrolyte imbalance and secondary constipation. Use with particular caution in patients with chronic inflammatory conditions in the abdomen, as well as in pregnant and breastfeeding women.
Accidental aspiration of paraffin into the respiratory tract may cause
very severe pneumonia. The risk particularly concerns elderly, debilitated patients, and those taking the medicine in a lying position (choking). In elderly patients, administration should be limited to truly necessary situations, using the lowest effective doses for as short a time as possible (2–3 weeks). Due to the risk of adverse effects, duration and frequency of use should be monitored in elderly patients.
Interactions:
For skin: lack of data. Orally: the medicine used may interfere with the absorption of fat-soluble vitamins, i.e. A, D, E and K, as well as concurrently administered oral medicines.
Use during pregnancy and breastfeeding:
For skin: no contraindications. Orally: consult a physician before use.
Effect on ability to drive and operate machinery:
The medicine does not affect psycho-physical performance.
Route and method of administration:
For skin: in adults and children, massage skin with a small amount of preparation as needed. Orally: unless otherwise directed by a physician: adults – usually 15–30 ml orally before bedtime (corresponding to 1–2 tablespoons).
Laxative effect usually occurs after 6–10 hours.
Overdose:
Administration of large doses may cause diarrhea.
Adverse effects:
For skin: not reported so far. Orally: may cause anal itching; paraffin leakage from the anus is frequently observed. Prolonged and non-compliant use of the medicine may lead to water-electrolyte imbalance and secondary constipation. Small amounts of liquid paraffin may accumulate in lymph nodes, causing inflammatory changes.
Storage:
Keep the medicine out of reach and sight of children.
Store in a dark place. Do not use after the expiry date.
Availability category: OTC - Medicinal product dispensed without prescription.
Expiry date: (month, year)
Responsible party: Laboratorium Farmaceutyczne „Avena” spółka jawna
Sokulska- Dura i Palmowski
ul. Leśna 42, 86-031 Osielsko
tel.: (052) 324 12 12
fax.: (052) 324 12 11
Permit number: IL – 3385/LN
Batch number:
EAN UCC barcode: 5909994338531

Information provided
in Braille system: